Cargando…
Commentary: Extracorporeal membrane oxygenation for patients with refractory Coronavirus Disease 2019 (COVID-19): What do we know and what do we need to learn?
Autores principales: | Jacobs, Jeffrey P., Falasa, Matheus P., Machuca, Tiago N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by The American Association for Thoracic Surgery
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713634/ https://www.ncbi.nlm.nih.gov/pubmed/33516461 http://dx.doi.org/10.1016/j.jtcvs.2020.11.128 |
Ejemplares similares
-
Cardiac surgery and the coronavirus disease 2019 pandemic: What we know, what we do not know, and what we need to do
por: Bakaeen, Faisal G., et al.
Publicado: (2020) -
Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018) -
Presbyopia: What We Do Know and What We Do Not Know in 2022
por: Grzybowski, Andrzej, et al.
Publicado: (2023) -
What do we know and when do we know it?
por: Nicholls, Anthony
Publicado: (2008) -
Multimorbidity: What do we know? What should we do?
por: Navickas, Rokas, et al.
Publicado: (2016)